Mesoridazine

From WikiMD.org
Jump to navigation Jump to search

Mesoridazine

Mesoridazine (pronounced: meh-so-ri-da-zine) is a piperidine neuroleptic drug belonging to the class of phenothiazine derivatives, used in the treatment of schizophrenia. It is a metabolite of thioridazine. The drug is a medium-potency antipsychotic and was used in the treatment of psychotic disorders including schizophrenia, psychosis, and severe anxiety before it was withdrawn in many countries due to cardiac toxicity.

Etymology

The term "Mesoridazine" is derived from the Greek words "mesos" meaning "middle" and "ridazine" which is a common suffix for phenothiazine derivatives. The name signifies its position as a metabolite of thioridazine, a more commonly used phenothiazine derivative.

Pharmacology

Mesoridazine acts as an antagonist of certain adrenergic, dopaminergic, histaminergic, and serotonergic receptors, leading to its antipsychotic effects. It is known to have a medium potency as an antipsychotic compared to other drugs in the phenothiazine class.

Side Effects

Common side effects of Mesoridazine include drowsiness, dizziness, and dry mouth. More serious side effects may include cardiac arrhythmias, neuroleptic malignant syndrome, and tardive dyskinesia. Due to the risk of cardiac toxicity, Mesoridazine is typically reserved for patients who have not responded to other antipsychotic treatments.

Related Terms

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski